140 related articles for article (PubMed ID: 1738415)
1. Control of predialytic hyperphosphatemia by oral calcium acetate and calcium carbonate. Comparable efficacy for half the dose of elemental calcium given as acetate without lower incidence of hypercalcemia.
Morinière P; Djerad M; Boudailliez B; el Esper N; Boitte F; Westeel PF; Compagnon M; Brazier M; Achard JM; Fournier A
Nephron; 1992; 60(1):6-11. PubMed ID: 1738415
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of calcium acetate and calcium carbonate for the control of predialysis hyperphosphatemia].
Djerad M; Morinière P; Westeel PF; el Esper N; Boitte F; Morsli R; Schenouda M; Compagnon M; Achard JM; Fournier A
Nephrologie; 1991; 12(4):193-7. PubMed ID: 1745337
[TBL] [Abstract][Full Text] [Related]
3. Long-term (6 months) cross-over comparison of calcium acetate with calcium carbonate as phosphate binder.
Ben Hamida F; el Esper I; Compagnon M; Morinière P; Fournier A
Nephron; 1993; 63(3):258-62. PubMed ID: 8446261
[TBL] [Abstract][Full Text] [Related]
4. Role of calcium carbonate administration timing in relation to food intake on its efficiency in controlling hyperphosphatemia in patients on maintenance dialysis.
Sechet A; Hardy P; Hottelart C; Rasombololona M; Abighanem O; Oualim Z; Brazier M; Achard JM; Pruna A; Moriniere P; Fournier A
Artif Organs; 1998 Jul; 22(7):564-8. PubMed ID: 9684692
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Calcium acetate versus calcium carbonate for the control of serum phosphorus in hemodialysis patients.
Almirall J; Veciana L; Llibre J
Am J Nephrol; 1994; 14(3):192-6. PubMed ID: 7977479
[TBL] [Abstract][Full Text] [Related]
7. [Role of the time of administration of calcium carbonate (before or during mealtime) in the control of hyperphosphatemia in patients on maintenance hemodialysis].
Séchet A; Abighanem O; Said S; Rasombololona M; Morinière P; Brazier M; Fournier A
Nephrologie; 1999; 20(4):209-12. PubMed ID: 10480153
[TBL] [Abstract][Full Text] [Related]
8. Comparison of calcium acetate with calcium carbonate as phosphate binder in patients on maintenance haemodialysis.
Saif I; Halim A; Altaf A; Saif M; Khalid M; Ahmad D; Imran H
J Ayub Med Coll Abbottabad; 2007; 19(4):26-8. PubMed ID: 18693591
[TBL] [Abstract][Full Text] [Related]
9. Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous 1-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaCO3 +/- Mg(OH)2.
Mornière P; Maurouard C; Boudailliez B; Westeel PF; Achard JM; Boitte F; el Esper N; Compagnon M; Maurel G; Bouillon R
Nephron; 1992; 60(2):154-63. PubMed ID: 1552999
[TBL] [Abstract][Full Text] [Related]
10. Calcium carbonate is an effective phosphate binder when dialysate calcium concentration is adjusted to control hypercalcemia.
Mactier RA; Van Stone J; Cox A; Van Stone M; Twardowski Z
Clin Nephrol; 1987 Nov; 28(5):222-6. PubMed ID: 3427832
[TBL] [Abstract][Full Text] [Related]
11. Use of alkaline calcium salts as phosphate binder in uremic patients.
Fournier A; Morinière P; Ben Hamida F; el Esjer N; Shenovda M; Ghazali A; Bouzernidj M; Achard JM; Westeel PF
Kidney Int Suppl; 1992 Oct; 38():S50-61. PubMed ID: 1405382
[TBL] [Abstract][Full Text] [Related]
12. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
[TBL] [Abstract][Full Text] [Related]
13. The treatment of uraemic hyperphosphataemia with calcium acetate and calcium carbonate: a comparative study.
Schaefer K; Scheer J; Asmus G; Umlauf E; Hagemann J; von Herrath D
Nephrol Dial Transplant; 1991; 6(3):170-5. PubMed ID: 1866045
[TBL] [Abstract][Full Text] [Related]
14. Calcium-enriched bread for treatment of uremic hyperphosphatemia.
Babarykin D; Adamsone I; Amerika D; Spudass A; Moisejev V; Berzina N; Michule L; Rozental R
J Ren Nutr; 2004 Jul; 14(3):149-56. PubMed ID: 15232793
[TBL] [Abstract][Full Text] [Related]
15. Calcium acetate versus calcium carbonate as phosphate binders in hemodialysis patients.
Caravaca F; Santos I; Cubero JJ; Esparrago JF; Arrobas M; Pizarro JL; Robles R; Sanchez-Casado E
Nephron; 1992; 60(4):423-7. PubMed ID: 1584317
[TBL] [Abstract][Full Text] [Related]
16. Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium.
Moriniere P; el Esper N; Viron B; Judith D; Bourgeon B; Farquet C; Gheerbrant J; Chapuy M; Van Orshoven A; Pamphile R
Kidney Int Suppl; 1993 Jun; 41():S121-4. PubMed ID: 8320904
[TBL] [Abstract][Full Text] [Related]
17. Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis.
Pflanz S; Henderson IS; McElduff N; Jones MC
Nephrol Dial Transplant; 1994; 9(8):1121-4. PubMed ID: 7800211
[TBL] [Abstract][Full Text] [Related]
18. Substitution of calcium carbonate for aluminum hydroxide in patients on hemodialysis. Effects on acidosis, on parathyroid function, and on calcemia.
Anelli A; Brancaccio D; Damasso R; Padovese P; Gallieni M; Garella S
Nephron; 1989; 52(2):125-32. PubMed ID: 2500612
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis.
Hardy P; Sechet A; Hottelart C; Oprisiu R; Abighanem O; Said S; Rasombololona M; Brazier M; Moriniere P; Achard JM; Pruna A; Fournier A
Artif Organs; 1998 Jul; 22(7):569-73. PubMed ID: 9684693
[TBL] [Abstract][Full Text] [Related]
20. Reduced risk of hypercalcemia for hemodialysis patients by administering calcitriol at night.
Schaefer K; Umlauf E; von Herrath D
Am J Kidney Dis; 1992 May; 19(5):460-4. PubMed ID: 1585935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
